Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Pharmacoepidemiology and Drug Safety|March 16, 2005
Trends and influences on use of antidiabetic drugs in England, 1992-2003Tom Walley, Dyfrig Hughes, Helen Kendall
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 11, 2019
Management of Patients Symptomatically Unresponsive to Levothyroxine: Natural Desiccated Thyroid Extract or the Combination of Levothyroxine and Liothyronine? A Research PriorityAdrian Heald, Mark Livingston, Dyfrig Hughes
Drug Safety|May 25, 2004
Clinical pharmacology: special safety considerations in drug development and pharmacovigilanceKwame N Atuah, Dyfrig Hughes, Munir Pirmohamed
Journal of Personalized Medicine|September 5, 2019
Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled TrialsDanielle Johnson, Dyfrig Hughes, Munir Pirmohamed, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 1, 2007
Methods for integrating medication compliance and persistence in pharmacoeconomic evaluationsDyfrig Hughes, Warren Cowell, Tamas Koncz, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2019
Systematic review: outcomes and adverse events from randomised trials in Crohn's diseaseHeather Catt, Dyfrig Hughes, Jamie J Kirkham, et al.
International Journal of Antimicrobial Agents|January 19, 2007
Non-compliance with antibiotic therapy for acute community infections: a global surveyJean-Claude Pechère, Dyfrig Hughes, Przemyslaw Kardas, et al.
JMIR Cardio|November 5, 2025
Patient Preferences for Using Remote Care Technology in Heart Failure: Discrete Choice ExperimentAhmed Al-Naher, Jennifer Downing, Dyfrig Hughes, et al.
BMC Health Services Research|March 26, 2016
Opportunity costs and local health service spending decisions: a qualitative study from WalesSarah Karlsberg Schaffer, Jon Sussex, Dyfrig Hughes, et al.
Pageof 7